DETAILS, FICTION AND API MANUFACTURING

“The current predicament has uncovered some structural weaknesses within the EU’s medicines supply chain plus a large dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides explained. She advised that provide chain issues be resolved within an EU pharmaceutical technique envisioned for being launched